Article
Responses of biomarkers of folate and riboflavin status to folate and riboflavin supplementation in healthy and colorectal polyp patients (the FAB2 Study).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2007
Powers Hilary J, Hill Marilyn H, Welfare Mark, Spiers Alison, Bal Wendy, Russell Jean, Duckworth Yvonne, Gibney Eileen, Williams Elizabeth A, Mathers John C
Abstract excerpt
Epidemiologic data suggest that increasing folate intake may protect against colorectal cancer. Riboflavin may interact with folate to modulate the effect. A double-blind randomized placebo-controlled intervention study (the FAB2 Study) was carried out in healthy controls and patients with colorectal polyps (adenomatous and hyperplastic) to examine effects of folic acid and riboflavin supplements on biomarkers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.